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Abstract
Simulation studies are computer experiments that involve creating data by pseudo-
random sampling. A key strength of simulation studies is the ability to understand
the behaviour of statistical methods because some ‘truth’ (usually some parameter/s
of interest) is known from the process of generating the data. This allows us to con-
sider properties of methods, such as bias. While widely used, simulation studies are
often poorly designed, analysed and reported. This tutorial outlines the rationale for
using simulation studies and offers guidance for design, execution, analysis, reporting
and presentation. In particular, this tutorial provides: a structured approach for plan-
ning and reporting simulation studies, which involves defining aims, data-generating
mechanisms, estimands, methods and performance measures (‘ADEMP’); coherent
terminology for simulation studies; guidance on coding simulation studies; a critical
discussion of key performance measures and their estimation; guidance on structur-
ing tabular and graphical presentation of results; and new graphical presentations.
With a view to describing recent practice, we review 100 articles taken from Vol-
ume 34 of Statistics in Medicine that included at least one simulation study and
identify areas for improvement.
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1 INTRODUCTION
Simulation studies are computer experiments that involve creating data by pseudo-random sampling from known probability
distributions. They are an invaluable tool for statistical research, particularly for the evaluation of new methods and for the
comparison of alternative methods. Simulation studies are much used in the pages of Statistics in Medicine, but our experience
is that some statisticians lack the necessary understanding to execute a simulation study with confidence, while others are over-
confident and so fail to think carefully about design and report results poorly. Proper understanding of simulation studies would
enable the former to both run and critically appraise published simulation studies themselves and the latter to conduct simulation
studies with greater care and report with transparency. Simulation studies are empirical experiments and statisticians should
therefore use knowledge of experimental design and analysis in running them. Aswe shall see, inadequacies with design, analysis
and reporting lead to uncritical use and interpretation of simulation studies. In this context, better understanding of the rationale,
design, execution, analysis and reporting of simulation studies is necessary to improve understanding and interpretation of the
findings.
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Simulation studies are used to obtain empirical results about the performance of statistical methods in certain scenarios, as
opposed to more general analytic (algebraic) results, which may cover many scenarios. It is not always possible, or may be
difficult, to obtain analytic results. Simulation studies come into their own when methods make wrong assumptions or data are
messy because they can assess the resilience of methods in such situations. This is not always possible with analytic results,
where results may apply only when data arise from a specific model.
‘Monte Carlo simulation’ means statistical techniques that use pseudo-random sampling, and has many uses that are not
simulation studies. For example, it is required to implement multiple imputation and Markov Chain Monte Carlo methods.
The remainder of this paper does not consider these uses, unless the properties of some such method are being evaluated by a
simulation study.
There are many ways to use simulation studies in medical statistics. Some examples are:
◦ To check algebra (and code), or to provide reassurance that no large error has been made, where a new statistical method has
been derived mathematically.
◦ To assess the relevance of large-sample theory approximations (e.g. considering the sampling distribution of an estimator) in
finite samples.
◦ For the absolute evaluation of a new or existing statistical method. Often a new method is checked using simulation to ensure
it works in the scenarios for which it was designed.
◦ For comparative evaluation of two or more statistical methods.
◦ For calculation of sample size or power when designing a study under certain assumptions(1).
This article is focused primarily on using simulation studies for the evaluation of methods. Simulation studies for this purpose
are typically motivated by frequentist theory and used to evaluate the frequentist properties of methods, even if the methods are
Bayesian(2, 3).
It seems that as a profession we fail to follow good practice regarding design, analysis, presentation and reporting in our
simulation studies, as lamented previously by Hoaglin & Andrews(4), Hauck & Anderson(5), Ripley(6), Burton et al.(7), and
Koehler, Brown & Haneuse(8). For example, few reports of simulation studies acknowledge that Monte Carlo procedures will
give different results when based on a different set of random numbers and hence are subject to uncertainty, yet failing to report
measures of uncertainty would be unacceptable in medical research.
There exist some wonderful books on simulation methods in general (6, 9, 10) and several excellent articles encouraging
rigour in specific aspects of simulation studies (for example (1, 4, 5, 8, 11, 12, 13, 14, 15, 16)) but, until now, no unified
practical guidance on simulation studies. This tutorial provides such guidance. More specifically we: introduce a structured
approach for planning and reporting simulation studies; provide coherent terminology for simulation studies; offer guidance on
coding simulation studies; critically discuss key performance measures and their estimation; make suggestions for structuring
tabular and graphical presentation of results; and introduce several new graphical presentations. This guidance should enable
practitioners to execute a simulation study for the first time and contains much for more experience practitioners. For reference,
the main steps involved, key decisions and recommendations are summarised in table 1 .
The structure of this tutorial is as follows. We describe a review of a sample of the simulation studies reported in Statistics
in Medicine Volume 34 (section 2). In section 3 we outline a systematic approach to planning simulation studies, using the new
‘ADEMP’ structure (which we define there). Section 4 gives guidance on computational considerations for coding simulation
studies. In section 5, we discuss the purposes of various performance measures and their estimation, stressing the importance
of estimating and reporting the Monte Carlo standard error (SE) as a measure of uncertainty due to using a finite number
of simulation repetitions. Section 6 outlines how to report simulation studies, again using the ADEMP structure, and offers
guidance on tabular and graphical presentation of results. Section 7 works through a simple simulation to illustrate in practice
the approaches that we are advocating. Section 8 offers some concluding remarks, with a short subsection (8.1) that considers
some future directions. Examples are drawn from the review and from the authors’ areas of interest (which relate mainly to
modeling survival data, missing data, meta-analysis and randomised trial design).
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TABLE 1 Key steps and decisions in the planning, coding, analysis and reporting of simulation studies
Section
PLANNING 3
Aims 3.1
⋅ Identify specific aims of simulation study.
Data-generating mechanisms 3.2
⋅ In relation to the aims, decide whether to use resampling or simulation from some parametric model.
⋅ For simulation from a parametric model, decide how simple or complex the model should be and
whether it should be based on real data.
⋅ Determine what factors to vary and the levels of factors to use.
⋅ Decide whether factors should be varied fully factorially, partly factorially or one-at-a-time.
Estimand / target of analysis 3.3
⋅ Define estimands and/or other targets of the simulation study.
Methods 3.4
⋅ Identify methods to be evaluated and consider whether they are appropriate for estimand/target iden-
tified. For method comparison studies, make a careful review of the literature to ensure inclusion of
relevant methods.
Performance measures 3.5, 5.2
⋅ List all performancemeasures to be estimated, justifying their relevance to estimands or other targets.
⋅ For less-used performance measures, give explicit formulae for the avoidance of ambiguity. 5.2
⋅ Choose a value of 푛sim that achieves acceptable Monte Carlo SE for key performance measures. 5.2, 5.3
CODING AND EXECUTION 4
⋅ Separate scripts used to analyse simulated datasets from scripts to analyse estimates datasets.
⋅ Start small and build up code, including plenty of checks.
⋅ Set the random number seed once per simulation repetition.
⋅ Store the random number states at the start of each repetition.
⋅ If running chunks of the simulation in parallel, use separate streams of random numbers (17).
ANALYSIS 5
⋅ Conduct exploratory analysis of results, particularly graphical exploration.
⋅ Compute estimates of performance and Monte Carlo SEs for these estimates. 5.2
REPORTING 6
⋅ Describe simulation study using ADEMP structure with sufficient rationale for choices.
⋅ Structure graphical and tabular presentations to place performance of competing methods side-by-
side.
⋅ Include Monte Carlo SE as an estimate of simulation uncertainty. 5.2
⋅ Publish code to execute the simulation study including user-written routines. 8
2 SIMULATION IN PRACTICE: A REVIEW OF STATISTICS IN MEDICINE, VOLUME 34
We undertook a review of practice based on articles published in Volume 34 of Statistics in Medicine (2015). This review
recorded information relevant to the ideas in this article. In this section we briefly outline the review but do not give results, which
instead are provided at relevant points. The raw data on which results are based are provided as a Stata file in the supplementary
materials (pared down, without comments).
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TABLE 2 Description of notation
휃 An estimand (conceptually); also true value of the estimand
푛obs Sample size of a simulated dataset
푛sim Number of repetitions used; the simulation sample size
푖 = 1,… , 푛sim Indexes the repetitions of the simulation
휃̂ the estimator of 휃
휃̂푖 the estimate of 휃 from the 푖th repetition
휃̄ the mean of 휃̂푖 across repetitions
Var(휃̂) the true variance of 휃̂, which can be estimated with large 푛sim
V̂ar(휃̂푖) an estimate of Var(휃̂) from the 푖th repetition
훼 the nominal significance level
푝푖 the p-value returned by the 푖th repetition
We restricted attention to research articles, excluding tutorials in biostatistics, commentaries, book reviews, corrections, letters
to the editor and authors’ responses. In the volume, there were a total of 264 research articles of which 199 (75%) included at
least one simulation study.
In planning the review, we needed to select a sample size. Most of the questions of interest involved binary answers. For
such questions, to estimate proportions with maximum standard error of 0.05 (occurring when the proportion is 0.5), we ran-
domly selected 100 articles that involved a simulation study, before randomly assigning articles to a reviewer. TPM reviewed 35
simulation studies, IRW reviewed 34 and MJC reviewed 31. In case the reviewer was an author or co-author of the article, the
simulation study was swapped with another reviewer. TPM also reviewed five of the simulation studies allocated to each of the
other reviewers to check agreement on key information (results on agreement are given in appendix APPENDIX A: and figure
A1 ).
3 PLANNING SIMULATION STUDIES USING ADEMP
For clarity about the concepts that will follow, we introduce some notation in table 2 . Note that 휃 is used to represent a
connceptual estimand and its true value.
In the following sections, we outline the ADEMP structured approach to planning simulation studies. This acronym comes
from: Aims, Data-generating mechanisms, Methods, Estimands, Performance measures.
3.1 Aims
In considering the aims of a simulation study it is instructive to first consider desirable properties of an estimator 휃̂ from a
frequentist perspective.
1. 휃̂ should be consistent: as 푛 → ∞, 휃̂ → 휃. It is also desirable that 휃̂ be unbiased for 휃 in finite samples: E(휃̂) = 휃 (though
arguably less important since unbiasedness is not an invariant property). Some estimators may be consistent but exhibit
small-sample bias (logistic regression for example).
2. The sample estimate V̂ar(휃̂) should be a consistent estimate of the sampling variance of 휃̂ (see for example (18)).
3. Confidence intervals should have the property that at least 100(1 − 훼)% of intervals contain 휃 (see section 5.2).
4. It is desirable that Var ̂(휃) be as small as possible: that 휃̂ be an efficient estimator of 휃.
There are other properties we might desire, but these tend to involve combinations of the above. For example, short average
confidence interval length may be desirable; this relates to (4) and its validity depends on (1), (2) and (3). Mean squared error is
a combination of (1) and (4). Further, properties may be traded off; small bias may be accepted if there is a substantial reduction
in Var ̂(휃).
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The aims of a simulation study will typically be set out in relation to the above properties, depending on what specifically
we wish to learn. A simulation study might primarily investigate: large- or small-sample bias (e.g. (19); precision, particularly
relative to other available methods (e.g. (20)); Variance estimation (e.g. (21)); or robustness to misspecification (e.g. (22)).
There is a distinction between simulation studies that offer a proof-of-concept, i.e. showing that a method is viable (or fallible)
in some settings, and those that aim to stretch or break methods, i.e. identifying settings where the method may fail. Both are
useful and important in statistical research. For example, one may be faced with two competing methods of analysis, both of
which are equally easy to implement. Even if the choice is unlikely to materially affect the results, it may be useful to have
unrealistically extreme data-generating mechanisms to understand when and how each method fails; e.g. (22).
Alternatively, it may be of interest to compare methods where some or all methods have been shown to work in principle
but the methods under scrutiny were designed to address slightly different problems. They may be put head-to-head in realistic
scenarios. This could be to investigate properties when one method is correct – How badly do others fail? – or when all are
incorrect in some way –Which is most robust? No method will be perfect and it is useful to understand how methods are likely
to perform in the sort of scenarios that might be expected in practice. However, such an approach poses tough questions in
terms of generating data: Does the data-generating mechanism favour certain methods over others? How can this be checked
and justified?One common justification is by reference to motivating data. However, in the absence of a broad spectrum of such
motivating data, there is a risk of failing to convince readers that a method is fit for general use.
3.2 Data-generating mechanisms
We use the term ‘data-generatingmechanism’ to denote how random numbers are used to generate a dataset. This is in preference
to ‘data-generating model’, which implies parametric models and so is a specific class of data-generating mechanism. It is not
the purpose of this article to explain how specific types of data should be generated. See Ripley (6) or Morgan (9) for methods
to simulate data from specific distributions. In planning a simulation study, it is usual to spend more time deciding on data-
generating mechanisms than any other element of ADEMP. There are many subtleties and potential pitfalls, some of which we
will mention below.
Data may be generated by producing parametric draws from a known model (once or many times), or by repeated resampling
with replacement from a specific dataset (where the true data-generating model is unknown). For resampling studies, the true
data-generating mechanism is unknown and resamples are used to study the sampling distribution. While parametric simulation
can explore many different data-generating mechanisms (which may be completely unrealistic), resampling typically explores
only one mechanism (which will be relevant for at least the study at hand).
The choice of data-generating mechanism(s) will depend on the aims. As noted above, we might investigate a method under a
simple data-generating mechanism, a realistic mechanism, or a completely unrealistic mechanism designed to stretch a method
to breaking point.
Simulation studies provide us with empirical results for specific scenarios. For this reason, simulation studies will often
involve more than one data-generating mechanism to ensure coverage of different scenarios. For example, it is very common to
vary the sample size of simulated datasets because performance often varies over 푛obs (see section 5.2 and figure 1 ).
Much can be controlled in a simulation study and statistical principles for designing experiments therefore can and should be
called on. In particular, there is often more than one factor that will vary across specific data-generating mechanisms. Factors
that are frequently varied are sample size (several values) and true parameter values (for example, setting one or more parameters
to be zero or non-zero). Varying these factorially is likely to be more informative than one-by-one away from a ‘base-case’
data-generating mechanism, as doing so permits the exploration of interactions between factors. There are however practical
implications that might make this infeasible. The first regards presentation of results (covered in section 6) and the second
computational time. If the issue is simply around presentation, it may be preferable to define a ‘base case’ but perform a factorial
simulation study anyway and, if results are consistent with no interaction, presentation can vary factors away from the base case
one-by-one.
If the main issue with executing a fully factorial design is computational time, it may be necessary for the simulation study
to follow a non-factorial structure. Three approaches are noted below.
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A first pragmatic check may be to consider interactions only where main effects exist. If performance seems acceptable and
does not vary according to factor A, it would seem unlikely to have chosen a data-generating mechanism that happened to exhibit
this property when performance would have been poor for other choices of data-generating mechanism.
A more careful approach could be taken based on making and checking predictions beyond the data-generating mechanisms
initially used; an idea similar to external validation. Suppose we have two factors, A and B, where A ∈ {1,… , 8} and B ∈
{1,… , 5} in the data-generating mechanism. The base-case is A = 1,B = 1. If the non-factorial portion of the design varies A
from 1 to 8 holding B = 1, and varies B from 1 to 5 holding A = 1, this portion of the simulation study could be used to predict
performance when A = 8,B = 5. Predictions may be purely qualitative (‘bias increases as A increases and as B increases so
when we increase both together we would expect even larger bias’), or quantitative (based on the marginal effects after fitting
a model to existing results, thereby producing explicit predictions at unexplored values of A and B). The simulation study can
then be re-run for that single data-generating mechanism, say A = 8,B = 5 and predictions compared with the empirical results
(with a responsibility to expore further when predictions are poor or incorrect).
Finally, a more satisfactory solution is of course to use a fractional factorial design for the data-generating mechanisms(23, 3).
We now issue some specific pitfalls to help readers in choosing data-generating mechanisms (specifically acknowledging
Stephen Senn’s input).
1. Resampling with replacement from a dataset but failing to appreciate that results are relevant to an infinite population with
the exact characteristics of that dataset. For example, if a trial had a non-significant result, the treatment effect is non-zero
in the implicit population(24).
2. Missing the distinction between the logical flow of Bayesian and frequentist simulation. Repeated simulation with a single
parameter value is explicitly frequentist. The fact that 휃̂ is on average equal to 휃 does not imply that 휃 is on average equal
to 휃̂.
3. Failing to distinguish between what the simulator can know and what the estimator can know(25).
4. Employing tricks in data-generation without appreciating that the resulting data are not what was desired. As an example,
suppose one wishes to simulate bivariate data with a desired푅2, say 0.3. For any given repetition, the observed푅2 will not
equal 0.3, but this could be fixed by scaling the residuals. This would produce unintended side effects for other statistics.
In our review, 97 simulation studies used some form of parametric model to generate data while three used resampling
methods. Of the 97 that simulated from a parametric model, 27 based parameter values on data, one based parameter values
partly on data, and the remaining 69 on no data. Of these 97, 91 (94%) provided the parameters used. The most careful example
(26) explored analysis of meta-analysis data and drew the design factors from empirical data on 14,886 performed meta-analyses
from 1,991 Cochrane Reviews. The total number of data-generatingmechanisms per simulation study ranged from 1 to 4.2×1010;
figure A2 (in the appendix) summarises aspects of the data-generating mechanisms. Where more than one factor was varied,
fully factorial designs were the most frequent, while some used partially factorial designs. None used any of the alternative
approaches we have described.
3.3 Estimands and other targets
The majority of simulation studies evaluate or compare methods for estimating one or more population quantities, which we
term estimands and denote by 휃. An estimand is usually a parameter of the data generating model, but is occasionally some
other quantity. For example, when fitting regression models with parameter 훃 = (훽0… 훽푐), the estimand may be a specific 훽, a
measure of prognostic ability, the fitted outcome mean, or something else. In order to choose a relevant estimand, it is important
to understand the aims of analysis in practice.
The choice of estimand is sometimes a simple matter of stating a parameter of interest. At other times, it is more subtle. For
example, a logistic regression model unadjusted for covariates implies a marginal estimand; a model adjusted for covariates
implied a conditional estimand with a different true value (this example is expanded on in section 3.4).
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TABLE 3 Possible targets of a simulation study and relevant performance measures
Statistical task Target Examples of performance Example
measures
Analysis
Estimation Estimand Bias, empirical SE, mean-
squared error, coverage
Kuss compares a number of existing methods in
terms of bias, power and coverage (26)
Testing Null hypothesis Type I error rate, power Chaurasia and Harel compare new methods inn
terms of type I and II error rates (27)
Model selection Model Correct model rate, sensitiv-
ity or specificity for covari-
ate selection
Wu et al. compare four new methods in terms of
‘true positive’ and ‘false positive’ rates of covari-
ate selection (28)
Prediction Prediction/s Measures of predictive accu-
racy, calibration, discrimi-
nation
Ferrante compares four methods in terms of mean
absolute prediction error, etc. (29)
Design
Design a study Selected design Sample size, expected sam-
ple size, power / precision
Zhang compares designs across multiple data-
generating mechanisms in terms of number of
significant test results (described as ‘gain’) and
frequency of achieving the (near) optimal design
(30)
Not all simulation studies evaluate or compare methods that concern an estimand. Other simulation studies evaluate methods
for testing a null hypothesis, for selecting a model, or for prediction. We refer to these as targets of the simulation study. The
same statistical method could be evaluated against multiple targets. For example, the best method to select a regression model
to estimate the coefficient of an exposure (targeting an estimand) may differ from the best model for prediction of outcomes
(targeting prediction). Where a simulation study evaluates methods for design, rather than analysis, of a biomedical study, the
design is the target.
Table 3 summarises different possible targets of a simulation study and suggests some performance measures (described
more fully in section 3.5) that may be relevant for each target, with examples taken from Volume 34.
In our review, 64 simulation studies targeted an estimand, 21 targeted a null hypothesis, eight targeted a selected model, three
targeted predictive performance, and four had some other target. Of the 64 targeting an estimand, 51 stated what the estimand
was (either in the description of the simulation study or elsewhere in the article). A figure detailing the number of estimands in
simulation studies that targeted an estimand is given in the appendix, figure A3 .
3.4 Methods
The term ‘method’ is generic. Most often it refers to a model for analysis, but might refer to a design or some procedure (such
as a decision rule). For example, (31) and (32) evaluated procedures that involved choosing an analysis based on the result of a
preliminary test in the same data.
In some simulation studies there will be only one method with no comparators. In this case, selecting the method to be
evaluated is very simple. When we aim to compare several methods in order to identify the best, it is important to include serious
contenders. There are two issues.
First, it is necessary to have knowledge of previous work in the area to understand which methods are and are not serious
contenders. Somemethods may be legitimately excluded if they have already been shown to be flawed, and it may be unnecessary
to include such methods if the only consequences are repetition of previous research and bloating of results. An exception might
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be if a flawed method is used frequently in practice (for example last observation carried forward with incomplete longitudinal
data, or the ‘3 + 3’ design for dose-escalation).
Second, code. New methods are sometimes published but not implemented in any software (for example (33) and (34)),
implemented poorly, or implemented in unfamiliar software. For methods that have not been implemented, it is hard to argue
that they should be included in simulation studies. Although R and Stata appear to dominate for user-written methods, it is not
uncommon to see methods implemented in other packages. See section 4.3 for a discussion of the situation where the methods
under consideration are not all implemented in one same package. Note that one important role of simulation is to verify that
code is correct.
Methods may also be excluded if they do not target the specified estimand/s. Understanding whether methods target an esti-
mand or not can be subtle. Returning to the example of randomised trial with a binary outcome, one might compare two logistic
regression analyses, one unadjusted and one adjusted for a covariate, where the estimand is the log odds ratio for randomised
group. In a simulation study, one would be likely to find that the two methods give different mean estimates, and it would be
tempting to conclude that at least one of the methods is biased. However, the two methods target different estimands – that is,
the true unadjusted and adjusted log odds ratios differ(35).
One way to tackle the problem of different estimands is to ensure that both methods estimate the same estimand: in the
example of the randomised trial using logistic regression, this would involve post-processing the adjusted regression results to
estimate the adjusted marginal odds ratio, which is the same estimand as the unadjusted analysis (36). This of course implies
that the adjustment vs. non adjustment is the method comparison we are interested in (it may not be), and that the conditional
estimand is simply a nuisance part of standard adjustment. An alternative (but coarser) way to tackle the problem is to target the
null hypothesis, if the two methods test the same null. In the logistic regression example described above, because the setting is
a randomised trial, the null hypothesis that the odds ratio equals 1 is the same whether the odds ratio is conditional or marginal.
The number of methods evaluated in our review of Volume 34 ranged from 1 to 33 (see figure A3 ).
Non-convergence and other related issues such as perfect prediction (‘separation’(37)) can blight some simulation studies. In
such situations, there is a conceptual issue with defining a method. A ‘pure’ method evaluation would simply assess performance
of a model when it converges. However, in practice, an analyst whose model fails to converge would not give up but explore
other models until one converges. Thus, evaluation of such a proceduremay be of interest in simulation studies. Crowther, Look
and Riley evaluated such a procedure(38): if a model failed to converge, they applied a model with more quadrature points. We
will commment further on this issue in section 5.2.
3.5 Performance measures
The term ‘performance measure’ describes a numerical quantity used to assess the performance of a method. The equivalent
term ‘operating characteristic’ is sometimes used, particularly in the context of study designs (see for example (39)). Statistical
methods for estimation may output for example an estimate 휃̂푖, an estimate of variance V̂ar(휃̂)푖 (or standard error ŜE(휃̂)푖), degrees
of freedom, confidence intervals, test statistics and more (such as an estimate of prognostic performance).
The performance measures required in a simulation study depend on the aims and what the study targets (see section 3.3).
When the target is an estimand, the most obvious performance measure to consider is bias: the amount by which 휃̂ exceeds 휃
on average (this can be positive or negative). Precision and coverage of (1 − 훼) confidence intervals will also be of interest.
Meanwhile, if the target is a null hypothesis, power and type I error rates will be of primary interest. A simulation study targeting
an estimand may of course also assess power and type I error.
The performance measures seen in our review are summarised in table 4 . The denominator changes according across per-
formance measures because some are not applicable for some simulation studies. Further, sometimes simulation studies had
secondary targets. For example, nine simulation studies primarily targeted a null hypothesis but secondarily targeted an estimand
and could have assessed bias, and one of these did so. For eight articles, some performance measures were unclear. In some, a
performance measure was given a name that its formula demonstrated to be misleading (an example is the term ‘mean error’,
which is bias, when the formula is for mean absolute error), emphasising the importance of clear terminology in simulation
studies.
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TABLE 4 Performance measures evaluated in review of Volume 34 (Frequency (and %))
Overall By primary target
Null hyp- Selected Predictive
Performance Estimand othesis model performance Other
measure (푛 = 64) (푛 = 21) (푛 = 8) (푛 = 3) (푛 = 4)
Convergence 12/85 (14%) 10/61 (16%) 1/15 (7%) 1/6 (17%) 0/2 0/1
Bias 63/80 (79%) 59/64 (92%) 1/9 (11%) 0/2 2/3 1/2
Empirical SE 31/78 (40%) 31/62 (50%) 0/9 0/2 0/3 0/2
Mean squared error 26/78 (33%) 22/62 (35%) 2/9 (22%) 0/2 1/3 1/2
Model SE 22/77 (29%) 21/62 (34%) 1/9 (11%) 0/2 0/3 0/1
Type I error 31/95 (33%) 8/62 (13%) 18/21 (86%) 4/6 0/3 1/3
Power 28/95 (29%) 8/63 (13%) 14/20 (17%) 4/6 0/3 2/3
Coverage 42/79 (53%) 39/63 (62%) 1/9 (11%) 0/2 1/3 1/2
Conf. int. length 11/80 (14%) 9/63 (14%) 0/10 0/2 1/3 1/2
Note – denominator changes across performance measures because not all are applicable in all simulation studies
TABLE 5 The different datasets that may be involved in a simulation study
Dataset Description and notes
Simulated A dataset of size 푛obs produced with some element of random-number
generation, to which one or more methods are applied to produce some
quantity relating to the target of the study, such as an estimate of 휃.
Estimates† Dataset containing 푛sim summaries of information from repetitions (e.g.
휃̂, ŜE(휃̂), indication of hypothesis rejection) for each combination of
data-generating mechanism, method and target (e.g. each estimand).
States Dataset of containing 푛sim+1 random-number-generator states: the start
state for each simulated dataset and the final state (see section 4.1).
Performance
measures
Dataset containing estimated performance and Monte Carlo standard
errors for each data-generating mechanism, method and target.
†or corresponding summaries for non-estimand targets
Description and estimation of common performance measures of interest are given in section 5. An important point to appre-
ciate in design and analysis is that simulation studies are empirical experiments, meaning performance measures are themselves
estimated, and estimates of performance are thus subject to error. This fundamental feature of simulation studies does not seem
to be widely appreciated, as previously noted(6). The implications are two-fold. First, we should present estimates of uncertainty
(quantified as the Monte Carlo standard error; see section 5.2). Second, we need to consider the number of repetitions 푛sim and
how this can be chosen (see section 5.2).
4 COMPUTATIONAL AND PROGRAMMING ISSUES IN SIMULATION STUDIES
In this section we discuss consideration when coding a simulation study. It is useful to understand what sort of data are involved.
There may be up to four classes of dataset, listed and described in table 5 .
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4.1 Random numbers: setting seeds and storing states
All statistical packages capable of Monte Carlo simulation use a pseudo-random-number generator. Each random number is
a deterministic function of the current ‘state’ of the random-number generator. After a random number is produced, the state
changes, ready to produce the next random number. Because the function is deterministic, the state can be set. Typically, the
state is set using a ‘seed’. Seeds do not necessarily map 1:1 to states, and provide doors onto the path of possible states. After
enough random-number draws (a very large number in software using modern pseudo-random-number generators), the state
will eventually repeat: the path is circular.
The ‘pseudo’ element to random-number generators is sometimes characterised as negative. This is perhaps an artefact of
the fact that some early algorithms provided very poor imitations of random numbers. However, modern-era algorithms such as
the Mersenne Twister do not suffer from these problems and can, for simulation purposes, be regarded as truly random when
used correctly. The toss of a coin or roll of a die may be regarded as equally deterministic, albeit the result of a complex set of
unknown factors that act in an uncontrollable fashion. These are not denigrated with the term ‘pseudo-random’: in statistical
teaching they are often given as the ultimate example of randomness. However, many stage magicians can control the flip of a
coin! If a computer pseudo-random number generator is sufficiently unpredictable and passes the various tests for randomness,
it is churlish to regard the ‘pseudo’ aspect as a weakness.
There are several positive implications of using a deterministic and reproducible process for generating random numbers.
First, if the number of repetitions is regarded as insufficient, the simulation study can continue from its end state. Second, and
more importantly, if a certain repetition results in some failure such as non-convergence, the starting state for that repetition
can be noted and the repetition re-run under that state, enabling better understanding of when the method does not work so
that issues leading to non-convergence can be tackled. Finally, the whole simulation study can be independently run by other
researchers, giving the potential for exact (rather than approximate) reproduction of results and the scope for additional methods
to be included.
Our practical advice for utilising the deterministic nature of random-number generators is simple but strong: 1. set the seed
at the beginning, once and only once; 2. store the state of the random-number generator often (ideally once at the beginning of
each repetition and once following repetition 푖 = 푛sim). This is important; the following chunk of pseudocode demonstrates the
concept:
SET RandomSeed to #
FOR Repetition 1 to n_sim by 1
STORE Repetition and RandomNumberState in StatesData[Repetition]
GENERATE simulated dataset
...
END FOR
STORE n_sim+1 and RandomNumberState in StatesData[n_sim+1]
The reason for this advice is to avoid unintended dependence between simulated datasets. We will illustrate our caution: one
undesirable method of knowing the states for 푛sim repetitions is to set an initial seed and generate a single vector of length 푛sim by
recording the starting state, generating a single random number, recording the new state, and so on. For the simulation itself, the
seed for the 푖th repetition is then set to the 푖th element. To clarify the problem, let 푛obs = 푛sim = 4 and let the first simulation step
be generation of vector 푥 from a Uniform(0,1) distribution. The first repetition simulates 푥1 (which changes the random number
state four times) and proceeds. The second repetition then simulates 푥2, which is made up of observations 2 to 4 from repetition
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푖 = 1 and just one new value. Run in Stata 15 (see supplementary material), the resulting draws of 푥 for the four repetitions are:
푥1 = (0.1338766, 0.1364070, 0.4512149, ퟎ.ퟎퟐퟏퟎퟐퟒퟐ)
푥2 = (0.1364070, 0.4512149, ퟎ.ퟎퟐퟏퟎퟐퟒퟐ, 0.3508981)
푥3 = (0.4512149, ퟎ.ퟎퟐퟏퟎퟐퟒퟐ, 0.3508981, 0.9113581)
푥4 = (ퟎ.ퟎퟐퟏퟎퟐퟒퟐ, 0.3508981, 0.9113581, 0.4707521)
Note that elements with the same shading contain the same values across rows: The fourth element of 푥1 is the first element of 푥4
and appears in all repetitions. Only when 푖 > 푛obs is the draw of 푥 actually independent of the first repetition. Such dependency
in simulated data can compromise both performance estimates and Monte Carlo SEs and must be avoided.
4.1.1 ‘Stream’ random numbers
It is common for parts of simulation studies – fractions of all the repetitions, for example – to be run in parallel on different
cores of high-performance computers (which this article will not mention further). If the advice to set the seed once only is
followed, the implication for parallelisation is that, while runs for different data-generating mechanisms may be parallelised, it
is inadvisable to parallelise repetitions within a specific data-generating mechanism.
Uncontrolled
parallel runs
Stream
parallel runs
Suppose we wish to parallelise two sets of 푛sim∕2 repetitions. Any simulation study will use random numbers (in order) from
a section of the circle. Here, each set of repetitions is represented by a clockwise arrow, and uses 80◦ of the total 360◦ of random
numbers available in the full circle (a caricature for illustrative purposes; in practice, a much smaller fraction would be used).
The seed dictates the position on the circle at which an arrow begins (and thus ends). The random numbers used up by the first
푛sim∕2 repetitions are represented by the red arrow and for the second 푛sim by the blue arrow. The left circle depicts two chunks
run in parallel with two different, arbitrarily-chosen starting seeds. By chance, they may overlap as seen. This would be a cause
for concern. The right circle uses separate streams of random numbers. This breaks the circle into quadrants, and setting the
same value of a seed within a stream means that the separate chunks will start at the equivalent point on the quadrants and here
there is no chance that one stream will enter another. In the absence of streams, repetitions should not be parallelised for the
same data-generating mechanism.
In Stata (version 15 or newer), the stream is set with
. set rngstream #
prior to setting the seed. In SAS, it is achieved within a data step with
. call stream(#);
In R, this can be achieved with the rstream package. Regardless of the package, the same seed must be used within different
values of #.
When a simulation study uses multiple data-generating mechanisms, these may be run in parallel. Because performance is
typically estimated separately for different data-generating mechanisms, using the same seeds is less of a problem (and may in
fact be advantageous, as described in section 5.4).
Many programs execute methods involving some stochastic element. Examples include multiple imputation, the bootstrap, the
g-computation formula, multistate models and Bayesian methods that use Markov Chain Monte Carlo. Commands to implement
these methods involve some random-number generation. It is important to check that such programs do not manipulate the seed.
Some packages do have a default seed if not input by the user. If they do set the seed internally, many of the 푛sim results will
be highly correlated, if not identical, and results should not then be trusted. Checking for such behaviour is worthwhile. One
simple technique is to display the current state of the random-number generator, twice issue the command, and display the state
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after each run. If the first and second states are the same then the program probably does not use random numbers. If the first
and second states differ but the second and third do not, the seed is being reset by the program.
4.2 Start small and build up code
As with any coding task it is all-too-easy to obtain misleading results in a simulation study through very minor coding errors;
see for example the comments section of (40), where fixing an error in a single line of code completely changed the results.
A function may be sloppily written as a-b*c such that it is unclear if (a-b)*c or a-(b*c) was intended; a machine will
interpret this code but will not discern the intention.
Errors are often detected when results are unexpected: for example, when bias appears much greater than theory suggests.
One design implication is that methods with known properties should be included where possible as a check that these properties
are exhibited. One straightforward and intuitive approach for minimising errors is to start small and specific for one repetition,
then build and generalise, including plenty of built-in checks.
In a simulation study with 푛sim > 1 and several simulated variables, a good starting point is to generate one simulated dataset
with large 푛obs. If variables are being generated separately then the code for each should be added one by one and the generated
data explored to 1) check that the code behaves as expected and 2) ensure the data have the desired characteristics. For example,
Stata’s rnormal(m,s) function simulates normal variates with mean m and standard deviation s. The usual notation for a
normal distribution uses a mean and variance. We have seen this syntax trip up several good programmers. By checking the
standard deviation of a variable simulated by rnormal() in a single large simulated dataset, it should be obvious if it does not
behave in the expected fashion. The simulation file should be built to include different data-generating mechanisms, methods or
estimands, again checking that behaviour is as expected. Using the above example again, if the basic data-generating mechanism
used N(휇, 1), the issue with specifying standard deviations vs. variances would not be detected, but it would for data-generating
mechanisms with 휎2 ≠ 1. When satisfied with the large dataset being generated, we apply each method.
Once satisfied that one large run is behaving sensibly, it is worth setting the required 푛obs for the simulation study and exploring
the simulated datasets produced under a handful of different seeds. When satisfied that the program still behaves sensibly, it may
be worth running a few (say tens of) repetitions. If for example convergence problems are anticipated, or bias is expected to be
0, this can be checked informally without the full set of simulations.
After thoroughly checking through and generalising code, the full set of 푛sim repetitions may be run. However, recall the
precaution in section 4.1 to store the states of the random-number generator and the reasons. If failure occurs in repetition
4, 120 of 5, 000, we will want to understand why. In this case, a record of the 4, 120th start state means we can reproduce the
problematic dataset quickly.
While the ability to reproduce specific errors is useful, it is also practically helpful to be able to continue even when an error
occurs. For this purpose, we direct readers to the capture command in Stata and the try command in R. The failed analysis
must be recorded as a missing value in the Estimates dataset, together with reasons if possible.
4.3 Using different software packages for different methods
It is frequently the case that competing methods are implemented in different software packages, and it would be more burden-
some to try and code them all in one package than to implement them in different packages. There are two possible solutions.
The first is to simulate data separately in the different packages and then use the methods on those data. The second is to simulate
data in one package and export simulated data so that different methods are based on the same simulated datasets.
Both approaches are valid in principle but we advocate the latter. First, if data are generated independently for different
methods, there will be different (random) Monte Carlo error affecting each repetition. By using the same simulated data for both
comparisons, this Monte Carlo error will affect methods’ performance in the same way because methods are matched on the
same generated data. Second, it is cumbersome to do a job twice, and because different software packages have different quirks,
it will not be easy to ensure data really are being generated identically. Third, it is important to understand that our aim is to
compare methods, and while the software implementation may be important to evaluate, the way the software package simulates
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data is not of interest: using a method in practice would involve a software implementation, but not simulating data using that
package. Whatever data an analyst was faced with would be the same regardless of the software being used.
Sixty two simulation studies in our review mentioned software. Table A1 (in the appendix) describes the specific statistical
software mentioned. Seven simulation studies mentioned using more than one statistical package.
5 ANALYSIS OF ESTIMATES DATA
This section describes estimation for various performance measures along with Monte Carlo SEs. We advocate two preliminar-
ies: checking for missing estimates and plots of the estimates data.
5.1 Checking the estimates data and preliminaries
The number of missing values, e.g. of 휃̂푖 and ŜE(휃̂푖) (for example due to non-convergence), is the first performance measure to
assess. The data produced under repetitions for which missing values were returned should be explored to understand how a
method failed (see section 4) and, ideally, the code made more robust to reduce the frequency of failures.
Missing values in the estimates dataset pose a missing data problem regarding the analysis of other performance measures.
It seems implausible that values would be missing completely at random(41); estimates will usually be missing due to non-
convergence so will likely depend on some characteristic/s of a given simulated dataset. When the ‘method’ being evaluated
involves an analyst’s procedure (as described in section 3.4), for example, the model changes if the first-choice model does not
converge, this can reduce or remove missing values from the estimates data (though it changes the nature of the method being
evaluated; see section 3.4).
If more than two methods are evaluated, and one always returns an estimate 휃̂푖, then missing values for another method may be
related to the returned values for the first method. In the presence of a non-trivial proportion of missing estimates data, analysis of
further performance measures should be tentative, particularly when comparing methods with different numbers of 휃̂푖 missing.
‘Non-trivial’ means any proportion that could meaningfully alter estimated performance. If we are interested in detecting tiny
biases, even 1% may be non-trivial.
Before undertaking a formal analysis of the estimates dataset, it is sensible to undertake some exploratory analysis. Plots are
often helpful here. For example, (31) assessed the performance of a two-stage procedure for the analysis of factorial trials. The
procedure was unbiased (both conditionally and unconditionally), yet a histogram of 휃̂푖 exhibited a bimodal distribution with
modes equally spaced at either side of 휃, with almost no values of 휃̂푖 close to 휃. This may cause concern and would have been
missed had the analysis proceeded straight to the estimation of performance.
For simulation studies targeting an estimand, the following plots are often informative:
1. A univariate plot of the distribution of 휃̂푖 and ŜE(휃̂푖) for each data-generating mechanism, estimand and method, to inspect
the distribution and, in particular, to look for outliers.
2. A bivariate plot of ŜE(휃̂푖) vs. 휃̂푖 for each data-generating mechanism, estimand and method, with the aim of identifying
bivariate outliers.
3. Bivariate plots of 휃̂푖 (and possibly ŜE(휃̂푖)) for one method vs. another for each data-generating mechanism and estimand.
The purpose here is to look for correlations between methods and any systematic differences. Where more than two
methods are compared, a graph of every method vs. every other or vs. the comparator can be useful.
4. Limits-of-agreement for 휃̂푖 (and possibly ŜE(휃̂푖)) compared with a reference method. That is, a plot of the difference vs.
the mean of each method compared with a comparator.
5. A plot of confidence intervals fractionally ranked by |푧| where 푧 = (휃̂푖 − 휃)∕ModSE푖 (as in figure 5 ). This is called a
zip plot and is a means of understanding any issues with coverage.
These plots will be demonstrated and interpreted in the worked example (section 7).
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5.2 Estimation of performance and Monte Carlo standard errors for some common performance
measures
This section outlines some common performance measures, properties they are designed to assess, how they are estimated and
how Monte Carlo standard errors are computed. We suppress the ‘hat’ notation for performance measures, but emphasise that
these are estimates.
For interpretation of results, performance measures should usually be considered jointly (one could prefer a method with zero
variance by conveniently ignoring bias).
Monte Carlo standard errors quantify simulation uncertainty: they provide an estimate of the SE of (estimated) performance
due to using finite 푛sim. The Monte Carlo SE targets the sampling distribution of repeatedly running the same simulation study
(with 푛sim repetitions) under different random-number seeds.
In our review of simulation studies in Statistics in Medicine Volume 34, 93 did not mention Monte Carlo SEs for estimated
performance. The formulas for computing Monte Carlo SEs given in table 6 with description and comments in the text. For
empirical SE, relative % increase in precision, and relative error, the Monte Carlo SE formulas assume normally distributed 휃̂;
for non-normal 휃̂, robust SEs exist – see (42).
Bias is frequently of central interest, and quantifies whether a method targets 휃 on average. Frequentist theory holds
unbiasedness to be a key property.
The mean of 휃̂푖, 휃̄, is often reported instead. This is estimated in the same way but without subtracting the constant 휃, and so
has the same Monte Carlo SE. It is sometimes preferable to report the relative bias, rather than absolute. If different values of 휃
are used for different data-generating mechanisms then relative bias permits a more straightforward comparison across values.
However, relative bias can be used only for |휃| > 0. The absence of bias is one property of an estimator; while it is often of
central interest, we may sometimes accept small biases because of other good properties.
The empirical SE is a measure of the precision or efficiency of the estimator of 휃. It depends only on 휃̂푖 and does not require
knowledge of 휃. The empirical SE estimates the long-run standard deviation of 휃̂푖 over the 푛sim repetitions. Several other des-
ignations are in common use; in our review, the terms used included ‘empirical standard deviation’, ‘Monte Carlo standard
deviation’, ‘observed SE’, and ‘sampling SE’.
The empirical standard error can be hard to interpret for a single method (unless compared to a lower bound), and the relative
precision is often of interest when comparing methods.
Note that, if either method is biased, relative precision should be interpreted with caution because an estimator that is biased
towards the null can have small empirical SE as a result of the bias: 휃̂푖∕2 has smaller empirical SE than 휃̂푖.
A related measure, which also takes the true value of 휃 into account, is the mean squared error (MSE). The MSE is the sum
of the squared bias and variance of 휃̂. This appears a natural way to integrate both measures into one summary performance
measure (low variance is penalised for bias), but we caution that, for method comparisons, the relative influence of bias and of
variance on the MSE tends to vary with 푛obs (except when all methods are unbiased), making generalisation of results difficult.
This issue is illustrated in the first three panels of figure 1 , which depict the bias, empirical standard error and root MSE
(favoured here because it is on the same scale as Empirical SE) for three hypothetical methods. Method A is unbiased but
imprecise (and so root MSE is simply the empirical SE); method B is biased, with bias constant over 푛obs, but more precise (as
is often the case with biased methods, see for example (43)); and method C, which is biased in a different way (bias ∝ √1∕푛obs)
and with precision the same as method B. For 푛obs < 60, root MSE is lower for method B than A, but for 푛obs > 60, root MSE
is lower for method A. The lesson is that comparisons of (root) MSE are more sensitive to choice of 푛obs than comparisons of
bias or empirical SE alone. MSE is nonetheless an important performance measure – particularly when the aims of a method
relate to prediction rather than estimation – but the implication is that, when MSE is a performance measure, data-generating
mechanisms should include a range of values of 푛obs.
We term the root-mean of the squared model SEs the ‘average model SE’. The aim of the model SE is that E(ModSE2) =
EmpSE2. The model SE explicitly targets the empirical SE. If it systematically misses, this represents a bias in the estimation of
model SE. The relative error in average model SE is then an informative performance measure (some prefer the ratio of average
model SE to empirical SE).
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TABLE 6 Performance measures: definitions, estimates and Monte Carlo standard errors
Performance
measure Definition Estimate Monte Carlo SE of estimate
Bias E[휃̂] − 휃 1
푛sim
푛sim∑
푖=1
휃̂푖 − 휃
√
1
푛sim(푛sim−1)
푛sim∑
푖=1
(휃̂푖 − 휃̄)2
EmpSE
√
Var(휃̂)
√
1
푛sim − 1
푛sim∑
푖=1
(휃̂푖 − 휃̄)2
ÊmpSE√
2(푛sim−1)
Relative % increase
in precision (B vs.
A) *
100
(Var(휃̂퐴)
Var(휃̂퐵) − 1
)
100
(( ÊmpSE퐴
ÊmpSE퐵
)2
− 1
)
200
( ÊmpSE퐴
ÊmpSE퐵
)2√ 1−Corr(휃̂퐴,휃̂퐵)2
푛sim−1
MSE E[(휃̂ − 휃)2] 1
푛sim
푛sim∑
푖=1
(휃̂푖 − 휃)2
√
푛sim∑
푖=1
[
(휃̂푖−휃)2−M̂SE
]2
푛sim(푛sim−1)
Average ModSE *
√
E[V̂ar(휃̂)]
√
1
푛sim
푛sim∑
푖=1
V̂ar(휃̂푖)
√
V̂ar[V̂ar(휃̂)]
4푛sim×M̂odSE
2 †
Relative % error in
ModSE * 100
(ModSE
EmpSE − 1
)
100
( M̂odSE
ÊmpSE − 1
)
100
( M̂odSE
ÊmpSE
)√ V̂ar[V̂ar(휃̂)]
4푛sim×M̂odSE
4 + 12(푛−1) †
Coverage Pr(휃̂low ≤ 휃 ≤ 휃̂upp) 1푛sim
푛sim∑
푖=1
1(휃̂low,푖 ≤ 휃 ≤ 휃̂upp,푖)
√
Ĉover.×(1−Ĉover.)
푛sim
Bias-eliminated
coverage Pr(휃̂low ≤ 휃̄ ≤ 휃̂upp) 1푛sim
푛sim∑
푖=1
1(휃̂low,푖 ≤ 휃̄ ≤ 휃̂upp,푖)
√
̂B-E Cover.×(1− ̂B-E Cover.)
푛sim
Rejection % (power
or type I error) Pr(푝푖 ≤ 훼) 1푛sim
푛sim∑
푖=1
1(푝푖 ≤ 훼)
√
P̂ower×(1−P̂ower)
푛sim
*Monte Carlo SEs are approximate for Relative % increase in precision, Average ModSE and Relative % error in ModSE.
†V̂ar[V̂ar(휃̂)] = 1
푛sim − 1
푛sim∑
푖=1
{
V̂ar(휃̂푖) − 1푛sim
푛sim∑
푗=1
V̂ar(휃̂푗)
}2
.
Coverage of confidence intervals is a key property for the long-run frequentist behaviour of an estimator. It is defined as the
probability that a confidence interval contains 휃.
Note that Neyman’s original description of confidence intervals defined the property of randomisation validity as exactly
100(1 − 훼)% of intervals containing 휃 (see (44, 45, 46)). Confidence validity is the property that the true percentage is at least
100(1−훼). This latter definition is less well known than the former, with the result that over- and under-coverage are sometimes
regarded as similarly bad(47). Of course, randomisation validity would usually be preferred over confidence validity because it
implies shorter intervals – but this is not always the case! There are examples of procedures that return both shorter intervals
and higher coverage (see for example (45, 46)).
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FIGURE 1 The impacts of bias and empirical SE on root MSE and coverage of nominal 95% confidence intervals, compared
for three methods: Method A is unbiased but imprecise; Method B is biased (independent of 푛obs) and more precise; Method C
is biased (with bias ∝ √1∕푛obs) and the same precision as method B. The comparison of root MSE and coverage depends on
the choice of 푛obs; the constant bias of method B dominates its increasingly poor MSE and coverage as 푛obs increases
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⋆Coverage calculated for normal-based confidence intervals of correct width so that bias is the source of undercoverage
Under-coverage is to be expected if, for example, i) Bias ≠ 0, ii) ModSE < EmpSE, iii) the distribution of 휃̂ is not normal
and intervals have been constructed assuming normality, or iv) V̂ar(휃̂푖) is too variable. Over-coverage tends to occur as a result
of ModSE2 > EmpSE2. This may occur either in the absence or presence of issues (i) and (iii).
Under-coverage due to bias will tend to deteriorate as 푛obs increases (unless bias reduces at or faster than a rate of
√
1∕푛obs ).
Intuitively, as 푛obs increases, confidence intervals zero-in on the wrong value. The situation is illustrated in the fourth panel of
figure 1 (with some loss of generality). Coverage was calculated for normal-based confidence intervals with correct interval
width such that bias is the only source of under-coverage. Method B, for which bias is independent of 푛obs, has deteriorating
coverage as 푛obs increases. Method C, for which bias ∝
√
1∕푛obs, has constant under-coverage. As for MSE, bias dominates as
푛obs increases. The implication is that, if coverage is being assessed in the presence of bias, the data-generating mechanisms
should include a range of values of 푛obs.
As noted previously, there are two sources of poor coverage: bias leads to under-coverage, while incorrect interval width
(for example because average ModSE ≠ EmpSE) may produce under- or over-coverage. We propose a decomposition of poor
coverage with a new performance measure: ‘bias-eliminated coverage’. By studying confidence interval coverage for 휃̄ rather
than for 휃, the bias of a method is eliminated from the calculation of coverage. We emphasise that bias-eliminated coverage
should not be regarded as a performance measure in its own right. It is to be used for understanding how coverage performance
is influenced by bias vs. width of confidence intervals. It is obvious that, for the methods in figure 1 , bias-eliminated coverage
will be equal for all methods.
Rejection rates – power and type I error – are often of principal interest in simulation studies that target a null hypothesis,
and power is of particular interest when competing designs are being compared by simulation. Assume we have p-values 푝푖 in
the estimates data and are considering nominal significance level 훼. The p-values may be derived from a Wald statistic 휃̂푖ŜE(휃̂푖)or output directly, for example by a likelihood-ratio test. An appropriate test would reject a proportion 훼 of the 푛sim repetitions
when the null is true and as often as possible when it is false. The obvious warning is that if the test does not control type I error
at level 훼, power should be interpreted with caution.
It is sometimes (not always) of interest to estimate conditional performance. This is particularly true for simulation studies that
aim to evaluate alternative study designs, for example where design decisions are made based on the early data. Two simulation
studies in our review sample explored two-stage procedures in randomised trials, where the estimand is selected after the first
stage: the estimand was the treatment effect in a selected subpopulation (48) or the effect of a selected treatment (49). In both
cases, estimators were designed to be conditionally unbiased. Kimani, Todd& Stallard reported bias conditional on each possible
selection of estimand (48), while Carreras, Gutjahr & Brannath considered the bias averaged across estimands (49). The former
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TABLE 7 Coverage conditional on size of ModSE
Approach 푛sim analysed Coverage (Monte Carlo SE)
All observations 30,000 95.0% (0.1%)
Conditional: ModSE in highest third 10,000 98.0% (0.1%)
Conditional: ModSE in middle third 10,000 95.5% (0.2%)
Conditional: ModSE in lowest third 10,000 91.5% (0.3%)
method is stricter and arguably more appropriate since, having selected an estimand, the observer is not interested in the other
case(50).
Now consider the following form of conditional performance: 푛obs = 30 observations are simulated from 푦 ∼ N(휇, 휎2), with
휇 = 0, 휎2 = 1. For each repetition, 95% confidence intervals for 휇 are constructed using the 푡-distribution. The process is
repeated 푛sim = 30, 000 times, and we study the coverage, 1) for all repetitions, and 2) according to tertiles of the model SE.
The results, given in table 7 , show that coverage is below 95% for the lowest third of standard errors, above 95% for the highest
third, and slightly above for the middle third. Poor conditional performance in this sense should not cause concern. Further, it is
unhelpful for an analyst faced with a dataset: one would not in practice know in which tertile of possible model SEs a particular
model SE lies.
Estimating performance conditional on true (rather than sample-estimated) parameters that vary across data-generating mech-
anisms is where methods should be expected to provide good performance, and we do not recommend averaging over these, as
is done informally in (51).
We have described the most commonly reported and generally applicable performance measures, particularly when a simulation
study targets an estimand. There are others that are sometimes used (such as the proportion of times the correct dose is selected
by dose–finding designs) and others that we have not yet thought of.
5.3 Sample size for simulation studies
In choosing 푛sim, the central issue is Monte Carlo error: key performance measures need to be estimated to an acceptable degree
of precision.
The values of 푛sim reported in our review are shown in figure A2 , panel d. Four simulation studies did not report 푛sim.
Common sample sizes are 푛sim = 500 and 푛sim = 1, 000, as previously reported by Burton et al.(7). Of the 87 studies reporting
푛sim, four provided any justification of the choice. These were:
• ‘To evaluate the asymptotic biases’ (52)
• ‘errors can be reduced by the large number of simulation replicates’ (53)
• ‘number was determined mainly to keep computing time within a reasonable limit. A reviewer pointed out that, as an addi-
tional justification, by using 10,000 meta-analyses the standard error of an estimated percentage (e.g., for the empirical
coverage) is guaranteed to be smaller than 0.5.’ (26)
• Most positively, Marozzi gave an explicit derivation of Monte Carlo SE (54)
Clearly this is a sub-optimal state of affairs. For some more concrete justifications, see the worked illustrative example in
section 7, Keogh and Morris(55), or Morris et al.(56)
There exist situations where only one repetition is necessary, particularly when investigating large-sample bias; see for
example (19). Here, the aim was to demonstrate large-sample bias of an estimator and the single estimate of 휃̂ was many model
standard errors from its true value.
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Where the key performance measure is coverage, 푛sim can be defined as follows. The Monte Carlo SE of coverage is given in
section 5.2. Plugging in the expected coverage (for example 95%) and rearranging, we get
푛sim =
E(Coverage) × (1 − E(Coverage))
(Monte Carlo SEreq)2
(1)
with a similar expression if 푛sim is to be determined based on power. For example, if the SE required for a coverage of 95% is
0.5%,
푛sim =
95 × 5
0.52
= 1, 900 repetitions.
Coverage is estimated from 푛sim binary summaries of the repetitions, so the worst-case SE occurs when coverage is 50%. In this
scenario, to keep the required Monte Carlo SE below 0.5% , (1) says that 푛sim = 10, 000 repetitions will achieve this Monte
Carlo SE.
A convenient feature of simulation studies is that the Monte Carlo SE can be assessed and 푛sim increased much more cheaply
than with other empirical studies. The cost is computational time. To continue, rather than start again, it is important to have a
record the end state of the random-number generator (which can be used as the seed if further repetitions are added) or to use a
different stream.
5.4 Remarks on analysis
We have emphasised repeatedly that simulation studies are empirical experiments. In many biomedical experiments, ‘controls’
are used as a benchmark and the estimated effects of other conditions are estimated as a contrast vs. control. However, simulation
studies often benefit from having a known ‘truth’, meaning that the contrast vs. a control is not often of interest (hence the term
‘comparator’ in section 3.4). That is, bias need not be estimated as the difference between 휃̄ − 휃 for method A and 휃̄ for the
control; rather the bias for a method stands alone, being computed against 휃, the comparator of interest. There are benchmarks
for other performance measures as well, such as coverage (the nominal %) and precision (the Cramér–Rao lower bound(57, 58)).
In some cases, the true value of 휃 is unknown: it may not appear in the data-generating mechanism. If performance measures
involving 휃 are not of interest, this poses no problem. Otherwise, one solution is to estimate 휃 by simulation. Williamson et al.
simulated data from a logistic model, but 휃 was not the conditional odds ratio used to generate data; 휃 was the marginal odds
ratio, risk ratio and risk difference(59). They thus estimated 휃 for each of these estimands from a large simulated dataset.
In our review of Volume 34, of 74 studies that included some 휃, nine estimated it, 57 used a known 휃 and 8 were unclear.
Estimating 휃 is in our view a sensible and pragmatic approach. However, such an approach must simulate a dataset so large
that it is fair to assume that the variance of ‘휃’ is negligible, particularly compared to that of 휃̄, and ensure that the states of
the random-number generators used in the simulation study do not overlap with the states used for the purpose of estimating 휃.
In practice, the way to do this is either to use a separate stream for the random numbers, or to run the 휃-estimation simulation
immediately before the main run.
The estimation of performance measures in section 5.2 is described for estimating performance once per data-generating-
mechanism. This is most suited to simulation studies with few data-generating mechanisms, but many simulation studies are
considerably more complex. In such cases, it is natural to fit a model (termed ‘meta-model’ by Skrondal(23)) for performance
in terms of the data-generating mechanisms.
An advantage of modeling performance across data-generating mechanisms is that we are able to match repetitions. This
reduces theMonte Carlo SE for the comparison of methods. For example, suppose that we have two data-generating mechanisms
with 휃 equal to 1 and 2. We could use the same starting seed so that results are correlated within 푖.
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6 REPORTING
6.1 The ‘methods’ section
The rationale for the ordering of elements in ADEMP is that this is usually the appropriate order to report them in a methods
section. If the simulation study has been planned and written out before it is executed, the methods section is largely written.
This is a particularly helpful ordering for other researchers who might wish to replicate the study. Details should be included
to allow reproduction as far as possible, such as the value of 푛sim and how this was decided on, dependence among simulated
datasets. Another important element to report is a justification of the chosen targets for particular applied contexts.
6.2 Presentation of results
Some simulation studies can be very small, for example exploring one or two performance measures under a single data-
generating mechanism. These can be reported in text (as in He et al. (60)). In other cases, there are enough results that it becomes
necessary to report them in tabular or graphical form. For any tabulation or plot of results, there are four potential dimensions:
data generating mechanisms, methods, estimands and performance measures. This section provides some considerations for
presenting these results.
In tabular displays, it is common to divide rows according to data-generating mechanisms and methods as columns (as in
Chen, et al.(61)), though if there are more methods than data-generating mechanisms it is better to swap these (as in Hsu, Taylor
and Hu (62)). Performance measures and estimands may vary across columns or across rows depending on what makes the table
easier to digest (see for example Alonso et al. (63)).
There are two key considerations in the design of tables. The first is how to place the important comparisons side-by-side.
The most important comparisons will typically be of methods, so bias (for example) for different methods should be arranged
in adjacent rows or columns.
The second consideration regards presentation of Monte Carlo SEs, and this tends to confound the first. By presenting them
next to performance results, for example in parentheses, the table becomes cluttered and hard to digest, obscuring interesting
comparisons. For this reason, some authors will report the maximum Monte Carle SE in the caption of tables (for example
(64, 43)). Results should not be presented to a greater accuracy than is justified by the Monte Carlo SE (e.g. 3dp for coverage).
In our review of Volume 34, seven articles presented Monte Carlo SEs for estimated performance: three in the text, two in a
table, one in a graph, and one in a float caption.
The primary advantage of graphical displays of performance is that it is easier to quickly spot patterns, particularly over
dimensions that are not compared side-by-side. A second advantage is that it becomes possible to present raw data estimates
(for example the 휃̂푖) as well as performance results summarising them (see for example figure 3 of (65)). In our experience,
these plots are popular and intuitive ways to summarise the 휃̂푖 and model SE’s. Another example of a plot of estimates data is
a histogram given in Kahan(31) (this was particularly important as Bias ≃ 0, but almost no 휃̂푖 was close to 휃). Even if plots of
estimates are not planned to be included in publications we urge their use in exploration of simulation results.
The main disadvantage of graphical displays of results is that plots can be less space-efficient than tables, it is not possible to
read the exact numbers, and separate plots will frequently be required for different performance measures.
Compared with tables, it is easier for plots of performance results to accommodate display of Monte Carlo SE’s directly, and
this should be done, for example as 95% confidence intervals. The considerations about design of plots to facilitate the most
relevant comparisons apply as with tables. Methods often have names that are hard to arrange side by side in a legible manner;
it is usually preferable to arrange methods in horizontal rows and performance measures across columns.
As noted previously, full factorial designs can pose problems for presentation of results. One option for presentation is to
present data assuming no interaction unless one is obviously present. An alternative approach taken by Rücker and Schwarzer is
to present all results of a full factorial simulation studywith 4×4×4×4×3 = 768 data-generatingmechanisms, and comparison of
six methods(66). Their proposal is a ‘nested-loop plot’, which loops through nested factors – usually data-generatingmechanisms
– for an estimand, and plots results for different methods on top of each other(66). This is a useful graphic but will not suit all
designs (and makes depiction of Monte Carlo SE difficult).
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There is no one correct way to present results, but we encourage careful thought to facilitate readability and clarity, considering
the comparisons that need to be made by readers.
7 WORKED ILLUSTRATIVE EXAMPLE
To make clear the ideas described in this article and demonstrate how they may be put into practice, we conduct one example
simulation study. We hope that the aims and methods are simple enough to be understood by all readers. Further, the files
required to run the simulation in Stata are available at https://github.com/tpmorris/simtutorial (with the addition of code for
other software planned).
7.1 Design of example
The example is a comparison of three different methods for estimating the hazard ratio in a randomised trial with a survival
outcome.
Consider the proportional hazards model, where we have the hazard rate (event rate at time 푡 conditional on survival until at
least time 푡) for the 푖th patient
ℎ푖(푡) = ℎ0(푡)exp(푋푖휃), (2)
with ℎ0(푡) the baseline hazard function, 푋푖 a binary treatment indicator variable coded 0 for control and 1 for the research
arm, and 휃 the log hazard ratio for the effect of treatment. There are various ways to estimate this hazard ratio, with common
approaches being the Cox model, and standard parametric survival models, such as the exponential andWeibull. The parametric
approaches make assumptions about the form of the baseline hazard function ℎ0(푡) whereas the Cox model makes no such
assumption. We now describe a simulation study to evaluate the three methods in this simple setting.
Aims: To evaluate the impacts 1) of misspecifying the baseline hazard function on the estimate of the treatment effect 휃; 2) of
fitting too complex a model when an exponential is sufficient; and 3) of avoiding the issue by using a semiparametric model.
Data-generating mechanisms: We consider two data-generating mechanisms. For both, data are simulated on 푛obs = 500
patients, representing a possible phase III trial with survival outcome. Let 푋푖 ∈ (0, 1) be an indicator denoting assignment
to treatment, where assignment is generated using 푋푖 ∼ Bern(0.5) – simple randomisation with an equal allocation ratio. We
simulate survival times from the model in equation 2, assuming that 휃 = −0.5, corresponding to a hazard ratio of 0.607 (3dp).
We let ℎ0(푡) = 휆훾푡훾−1. The two data-generating mechanisms differ only in the values of 훾:
1: 휆 = 0.1, 훾 = 1 ← both an exponential and a Weibull model
2: 휆 = 0.1, 훾 = 1.5 ← a Weibull but not an exponential model
A plot of the hazard rate ℎ푖(푡) for the two data-generating mechanisms is given in figure 2 .
Data are simulated using Stata 15 using the 64-bit Mersenne twister for random number generation. The input seed is ‘72789’.
Estimands:Our estimand 휃 is the log-hazard ratio for푋 = 1 vs.푋 = 0, which would represent a treatment effect in a randomised
trial.
Methods: Each simulated dataset is analysed in three ways, using:
1. An exponential proportional-hazards model
2. A Weibull proportional-hazards model
3. A Cox proportional-hazards model
Note that the exponential model is correctly specified for the first data-generating mechanism but misspecified for the second;
the Weibull model is correctly specified for both mechanisms; and the Cox model does not make any assumption about the
baseline hazard so is not misspecified for either mechanism.
Performance measures:We will assess convergence, bias, coverage, empirical and model-based standard errors for 휃̂.
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FIGURE 2 Visualisation of the true hazard rate over follow-up time in the two data-generating mechanisms. Black (flat) lines
are for the first data-generating mechanism where 훾 = 1; red curves are for the second, where 훾 = 1.5
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Bias is our key performance measure of interest, and we will assume that SD(휃̂) ≤ 0.2, meaning that Var(휃̂) ≤ 0.04. (A
conservative estimate based on an initial small simulation run.) We decide that we require Monte Carlo SE of bias to be lower
than 0.005. Given that
Monte Carlo SE(Bias) =
√
Var(휃̂)∕푛sim,
this implies that we need 1,600 repetitions. If coverage of all methods is 95%, the implication of using 푛sim = 1, 600 is
Monte Carlo SE(Coverage) =
√
95 × 5
1, 600
= 0.54.
With 50% coverage, the Monte Carlo SE is maximised at 1.25. We consider this satisfactory and so proceed with 푛sim = 1, 600
(to be revised if, for example, SD(휃̂) > 0.2).
7.2 Exploration and visualisation of results
The first result to note is that there were no missing 휃̂푖 or ŜE(휃̂푖), and ‘separation’ was not an issue.
We first explore the raw results. Figure 3 plots the estimates 휃̂푖 and ŜE(휃̂)푖 for the two data-generating mechanisms and three
methods, with means displayed as yellow pipes. The left panels plot 휃̂푖. It is clear that, when 훾 = 1, the mean and variance of 휃̂푖
is very similar for the three methods. The mean is close to the true value of 휃 = −0.5 for all methods. When in truth 훾 = 1.5,
the empirical SE is slightly higher for all methods (because there are fewer events among the 500 observations under this data-
generating mechanism). The exponential proportional-hazards model is now misspecified and we observe a shift of the mean
of 휃̂푖 towards the null, indicating some bias. The right panels of figure 3 plot the estimated standard errors ŜE(휃̂)푖. These are
smaller for the upper panel (훾 = 1) than the lower panel (훾 = 1.5) but there is little to choose between the methods.
We next compare these estimates by plotting 휃̂푖 for eachmethod vs. every other method, and the same for ŜE(휃̂)푖. The data pairs
come from the same repetition (i.e. they are estimated in the same simulated dataset) and are compared to the line of equality.
This is done in figure 4 (a), for the second data-generating mechanism only (훾 = 1.5), of interest because the exponential model
is misspecified. We can see that the estimates of both 휃̂푖 and ŜE(휃̂푖) are highly correlated across all methods. The upper triangle
of plots in figure 4 shows that, while 휃̂푖 is almost identical for the Weibull and Cox models, it tends to be systematically closer
to 0 for the exponential model. The estimates of ŜE(휃̂푖) show that again, the estimates are extremely similar for the Weibull and
Cox models, and are very slightly larger for the exponential model. Figure 4 (B) gives the corresponding plots of the difference
vs. mean (Weibull is the comparator method here as it is correctly specified).
Figure 5 is a new visualisation, the ‘zip plot’, which helps to understand coverage by viewing the confidence intervals directly
(implemented in Stata; for implementations in R and SAS, see (67) and (68) respectively). For each data-generating mechanism
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FIGURE 3 Plot of the 1,600 휃̂푖 (left panels) and ŜE(휃̂)푖 (right panels) by data-generating mechanisms, for the three analysis
methods. The vertical axis is repetition number, to provide some separation between points. The yellow pipes are sample means.
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FIGURE 4 Comparison of estimates for methods when 훾 = 1.5, where each point represents one repetition. Panel (A): Upper
triangle displays 휃̂푖; lower triangle displays ŜE(휃̂푖). Panel (B): Plot of difference vs. mean for 휃̂푖 and ŜE(휃̂푖), with Weibull as the
comparator.
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and method, the confidence intervals are fractional-centile-ranked according to |푧|, where 푧 = (휃̂푖 − 휃)∕ModSE. This ranking
is used for the vertical axis and is plotted against the intervals themselves. Intervals which cover 휃 are coloured blue (bottom);
those which do not cover are coloured purple (top). When a method has 95% coverage, the colour of the intervals switches at 95
on the vertical axis. The yellow horizontal lines are Monte Carlo 95% confidence intervals for per cent coverage. (As a general
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FIGURE 5 ‘Zip plot’ of the 1, 600 confidence intervals for each data-generating mechanism and analysis method. The vertical
axis is the fractional centile of |푧| with 푧 = (휃̂푖 − 휃)∕ModSE associated with the confidence interval.
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comment, note that the interesting area in many zip plots will be near to the top and so it will often be more informative to
‘zoom in’ on the action, as suggested by Rick Wicklin in (68).)
In figure 5 , the upper panel again displays the results when 훾 = 1 and the lower panel when 훾 = 1.5. Despite coverage being
approximately 95% as advertised, there are more intervals to the right of 휃 = −0.5 than to the left, particularly for those that do
not cover 휃. This indicates that the model SEs must overestimate the empirical SE, because coverage is adequate despite bias.
A zip plot helps to make such a feature clear.
7.3 Analysis of example
The previous section demonstrated some exploratory analyses that may be of value. Next, we estimate performance for the
measures of interest and present them in a table for which (we hope) the ADEMP structure is clear: different performancemeasures
are stacked vertically; for each performance measure, the results for the two data-generating mechanisms each occupy one row;
results for different methods are arranged across three columns (with Monte Carlo SEs in parentheses at a smaller point size
than the estimate); there is only one estimand.
Also given in figure 6 is an alternative graphical presentation of estimated performance called a lollipop plot. The ADEMP
structure is slightly different to the table but again clear: different performance measures are stacked vertically; for each perfor-
mance measure the results for the three methods now occupy one row each; results for different methods are arranged across
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TABLE 8 Estimates of performance for measures of interest (Monte Carlo SEs in parentheses). Concerning results are highlighted in
bold. See also figure 6 .
Performance Data-generating Method
measure mechanism Exponential Weibull Cox
Bias 훾 = 1 −0.003 (0.005) −0.003 (0.005) −0.002 (0.005)
훾 = 1.5 0.049 (0.003) 0.005 (0.004) 0.006 (0.004)
Coverage 훾 = 1 95.4% (0.5) 95.4% (0.5) 95.4% (0.5)
훾 = 1.5 96.0% (0.5) 95.6% (0.5) 95.8% (0.5)
Bias-eliminated 훾 = 1 95.6% (0.5) 95.3% (0.5) 95.4% (0.5)
coverage 훾 = 1.5 97.2% (0.4) 95.7% (0.5) 96.1% (0.5)
Empirical SE 훾 = 1 0.209 (0.004) 0.209 (0.004) 0.209 (0.004)
훾 = 1.5 0.138 (0.002) 0.152 (0.003) 0.151 (0.003)
Relative precision 훾 = 1 0.2% (0.1) 0 (–) 0.3% (0.1)
gain vs.Weibull 훾 = 1.5 20.5% (0.4) 0 (–) 0.6% (0.2)
Model SE 훾 = 1 0.208 (<0.001) 0.208 (<0.001) 0.208 (<0.001)
훾 = 1.5 0.154 (<0.001) 0.154 (<0.001) 0.154 (<0.001)
Relative error in 훾 = 1 −0.7% (1.8) −0.7% (1.8) −0.5% (1.8)
Model SE 훾 = 1.5 11.5% (2.0) 1.7% (1.8) 2.1% (1.8)
the two columns. Monte Carlo 95% confidence intervals are now represented via parentheses (a visual cue due to the usual
presentation of intervals as two numbers within parentheses).
The results confirm more formally some of the features we saw in our exploration of the estimates data. The interesting
features concern the exponential model when 훾 = 1.5, since the Weibull and Cox models behave well in all cases. We see that
the exponential model suffers some bias towards the null, which is approximately 10% of the true value. This is non-negligible.
Next, we see that coverage is still over the nominal 95%, which is surprising in the presence of bias. The empirical SE is the
same for all models when 훾 = 1 and lowest for the exponential model when 훾 = 1.5, while the Weibull and Cox models are very
similar; recall however that in the presence of different biases, the empirical SE is not comparable across methods. For relative
precision (vs. the Weibull model) a very similar pattern is seen as for empirical SE. The Model SE is the same for all methods
and data-generating mechanisms. This explains why the exponential model has acceptable coverage when 훾 = 1.5: the bias is
cancelled out by the fact that the model SE is overestimated. This is confirmed by the relative error in Model SE.
Looking at table 8 , the Monte Carlo SEs of performance estimates are all acceptable and so we would be happy to draw
conclusions about the methods based on the 1,600 repetitions.
7.4 Conclusions of example
When an exponential model is misspecified, the hazard ratio can be biased. Probably not by much. Further research is needed.
More seriously, note that the data-generating mechanisms we used do not cover any real breadth of scenarios. For example,
we might have explored varying 푛obs, 휆 and 휃 over a range of values to explore when issues are present.
8 CONCLUDING REMARKS
Simulation studies are an invaluable tool for research into statistical methods, evidenced by the large proportion of Volume 34
Statistics in Medicine articles whose conclusions relied in part on simulation studies. Because methods promoted may be used
in medical research (or many other scientific areas), transparent reporting of the design and execution of simulation studies is
critical.
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FIGURE 6 Lollipop plot of performance for measures of interest (Monte Carlo 95% confidence intervals in parentheses).
Concerning features need not be highlighted since they are readily visible. See also table 8 .
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While simulation studies are widely used, they tend to be poorly reported by those who publish their results.
There are many areas to be improved in the reporting of simulation studies. Our view is that the two main shortcomings are (i)
lack of clarity over the design, which ADEMP aims to deal with, and (ii) failure to report estimates of Monte-Carlo uncertainty.
We have described – and advocate – a structured approach to the planning of simulation studies that involves identifying
aims, data-generating mechanisms, methods, estimands and performance measures. All of these and the rationale for decisions
should be included in reporting. For an excellent example of a clearly described design, see Austin and Stuart(69). Reports of
simulation studies are now beginning to explicitly use the ADEMP structure; see Thompson et al.(70), Sayers et al.(71), Morris
et al.(56), Keogh & Morris(55) and Pham et al.(72).
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We have given formulas for computing the Monte Carlo standard error for the most common performance measures, and
made some suggestions about reporting. Note that the Stata package simsum(12) and R package rsimsum(67) automate this
process for commonly used performance measures. See Boos and Osborne for more general assessment of Monte Carlo SEs for
complex performance measures(73).
8.1 Future directions
Three areas that we regard as of increasing future importance are simulation protocols, release of code, and consortia of authors.
We discuss these as a step towards resolving occurrences of simulation studies with contradictory results.
A charitable view of such contradictory results, which we tend to hold, is that methods are developed by researchers who
concerned with handling the specific problems they have seen in practice. Given such a background, they are running the relevant
simulation studies (that may not be relevant to others). A less charitable possibility might be selective reporting of only the most
favourable (or unfavourable) configurations of data-generating mechanisms, running the simulations many times under different
seeds and selecting the most favourable(3), and more (left to the reader’s imagination).
A starting point to addressing this issue is to write detailed simulation protocols before writing code. This would ideally
protect against authors choosing to report favourable results and force one to be clear about ‘ADEMP’ in advance. Of course, the
weak point is that simulation studies do not to need approval before ‘data collection’, so protocols could be written after-the-
fact and this cannot be clear even with published protocols. The counterargument is that protocols must justify the rationale for
choices: as well as describing what is planned, there is a burden to explain why.
Due to the prejudices introduced by experiences of data, it is constructive for authors who have produced contradictory
simulation results to work together on ‘late-phase’ simulation studies (using an analogy from clinical trials in drug development).
This allows robust discussion of the design and exploration of disparities among previous work. One exemplar of such an
approach is in methods for handling incomplete data where the analysis has a multilevel structure. Three groups of researchers
had developed methods and worked together on understanding how the methods differ and on simulation studies to evaluate
their performance, resulting in the paper by Audigier et al(74). This approach is in our view more satisfactory than a group of
researchers executing a large, late-phase simulation study without the input of authors of previous work, though this strategy is
sometimes adopted(75).
Boulestix, Wilson and Hapfelmeier raise an important consideration (76) for benchmarking studies that is also relevant to
late-phase simulation studies: it is easy to assume that the performance of methods is due entirely to the methods themselves,
but this ignores the fact that the implementation of a method involves the knowledge and skill of the individuals involved. A
poor implementation may make a superior method appear weak. This suggests again that including consortia of authors, as in
Audigier et al., is advisable.
No simulation study is definitive and new methods or refinements of methods are inevitable. For researchers wishing to
replicate or extend the results of earlier simulation studies, the design of earlier work must have been written out fully and
unambiguously. This can be a difficult task and, to ensure this, authors should release simulation code publicly (a policy that is
now encouraged by some journals, notably Biometrical Journal, and required by others). The happy corollary is that code may
be checked more thoroughly by its authors if it is subject to external scrutiny. There is generally no excuse for withholding code.
One caveat is for resampling studies, where permissions to release the original data may be lacking (note that code for running
the simulation can still be made available even if it cannot be run on the same data).
8.2 Final remark
Simulation studies are a powerful tool. However, it is important to be aware that, because a simulation study took hard work and
thought, we are liable to believe it tells us more than it truly does. To quote Patrick Royston, ‘Simulation studies reveal points
of light on a landscape, but can not illuminate the entire landscape.’ We can hope and plan to illuminate important points and
to build up a picture of the landscape, particularly where terrain may be particularly rocky or particularly fertile.
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We hope that the guidance in this tutorial will improve researchers’ understanding, planning, execution and future reporting
of simulation studies.
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FIGURE A1 Reviewer agreement on key variables for Statistics in Medicine Volume 34 review. Frequency of agreement of
TPM with IRW (marker W) and MJC (marker C). For the same frequency, C is nudged left and W right to avoid visual clash.
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APPENDIX A: REVIEW: FURTHER INFORMATION
Agreement between TPM and each of the other authors was measured on 14 key variables for the review (IRW and MJC did not
review any of the same articles). The variable-by-variable results are given in figure A1 . Note that for some variables, there
were two possible choices (e.g. ‘Results given in a figure Y/N’) while for others there were many (e.g. ‘Number of repetitions
푛sim’). Overall, TPM agreed with the other reviewers in 132 of 140 answers (94%). IRW and TPM agreed on 65 of 70 answers
(93%); MJC and TPM agreed on 67 or 70 answers (96%).
Figure A2 gives summary information about how data were generated. Panel (a) shows that there was great variation in the
total number of data-generating mechanisms, with the majority of simulation studies using under 20, and the largest number
being ∼ 41 billion. Panel (b) shows that simulation studies tended to vary few factors (with one exception). For the simulation
studies varying more than one factor, the most common way to do this was in a fully factorial manner (panel (c)). However,
some studies varied the factors one-at-a-time and others mixed the two together. Unfortunately, not all simulation studies noted
the number of repetitions (panel (d)). The most common choices of 푛sim were, in descending order: 1, 000, 500 and 10, 000.
Figure A3 a shows the number of estimands evaluated by the simulation studies included in the review. In general, there were
few, with a single estimand the most common. Figure A3 panel (b) gives the number of methods evaluated by the simulation
studies included in the review (right panel). The majority evaluated few methods (with four the most common number). This
suggests that simulation studies provide a proof-of-concept, or that the methods are designed for new problems for which there
are few alternatives available.
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TABLE A1 Software mentioned in simulation reports, review of Statistics in Medicine Volume 34. Note that there are more
than 100 entries as some articles reported more than one package.
Software Freq.
None mentioned 38
C 1
JAGS 1
MATLAB 1
R 41
SAS 17
SaTScan 1
Stata 4
StatXact 1
WinBUGS 3
Table A1 lists the software packages mentioned and the number of mentions in simulation studies included in the review.
This was based on a lenient judgement: for example, many articles mentioned a software package in which a method was
implemented but did not mention what software was used to run the simulation study.
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FIGURE A2 Results of Statistics in Medicine Volume 34 review for data-generating mechanisms. Values are both frequency
and %
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FIGURE A3 Results of Statistics in Medicine Volume 34 review for estimands (a) and methods (b) evaluated.
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